NACL Industries is currently trading at Rs. 43.90, up by 0.15 points or 0.34% from its previous closing of Rs. 43.75 on the BSE.
The scrip opened at Rs. 43.70 and has touched a high and low of Rs. 44.60 and Rs. 43.60 respectively. So far 4629 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 68.85 on 08-Jan-2018 and a 52 week low of Rs. 25.70 on 22-May-2017.
Last one week high and low of the scrip stood at Rs. 45.60 and Rs. 42.00 respectively. The current market cap of the company is Rs. 690.88 crore.
The promoters holding in the company stood at 74.62%, while Institutions and Non-Institutions held 2.04% and 23.34% respectively.
NACL Industries has entered into a Strategic Alliance Agreement with BioWorks, one of the leading player in USA in Agricultural Bio-Products space.
BioWorks focuses on developing green, environment friendly solutions for pest management and nutritional requirements of various crops in Agriculture, Horticulture, Turf & ornamentals and Home gardens. BioWorks is marketing a range of Bio-Products mainly in USA, Canada.
BioWorks has entered into a long term strategic alliance with the company inter-alia providing rights to NACL to exclusively market various BioWorks products in India and other countries in South Asia.
NACL Industries produces a comprehensive range of pesticide Technicals and Formulations.
| Company Name | CMP |
|---|---|
| UPL | 602.10 |
| PI Industries | 2731.25 |
| Bayer CropScience | 4218.45 |
| Sharda Cropchem | 872.90 |
| Sumitomo Chem. India | 520.10 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: